Capital World Investors - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 191 filers reported holding HAEMONETICS CORP in Q1 2014. The put-call ratio across all filers is 3.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital World Investors ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2021$20,858,000
-85.4%
313,000
-75.7%
0.00%
-84.6%
Q1 2021$142,936,000
+1.8%
1,287,600
+8.9%
0.03%
-3.7%
Q4 2020$140,434,000
+92.6%
1,182,600
+41.5%
0.03%
+68.8%
Q3 2020$72,932,000
+31.3%
835,900
+34.8%
0.02%
+23.1%
Q2 2020$55,536,000
+97.4%
620,100
+119.6%
0.01%
+62.5%
Q1 2020$28,136,000
-67.5%
282,322
-86.3%
0.01%
-66.7%
Q4 2013$86,577,000
+56.9%
2,055,000
+48.6%
0.02%
+41.2%
Q3 2013$55,165,0001,383,2740.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2014
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders